Guidant Announces First Implant of VENTAK AV III DR Defibrillation System.INDIANAPOLIS--(BW HealthWire)--May 1, 1998--Guidant Corporation (NYSE NYSE See: New York Stock Exchange :GDT GDT Global Descriptor Table GDT Geographic Data Technology Inc. GDT Gas Discharge Tube (energy, electrotechinical and electronics) GDT Getting Things Done GDT Geometric Dimensioning & Tolerancing GDT Ground Data Terminal ) (PCX (1) A bitmapped graphics file format that handles monochrome, 2-bit, 4-bit, 8-bit and 24-bit color and uses RLE to achieve compression ratios of approximately 1.1:1 to 1.5:1. Images with large blocks of solid colors compress best under the RLE method. See PC Paintbrush. :GDT), a worldwide leader in implantable defibrillation Defibrillation Definition Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm. systems, today announced the first implant of the VENTAK(R) AV(TM) III DR AICD AICD activation-induced cell death; automatic implantable cardioverter-defibrillator. (TM) Automatic Implantable Cardioverter Defibrillator system. Manufactured by Guidant's Cardiac Rhythm Management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. Group (CRM), the VENTAK AV III DR is a downsized, full-featured pacing and defibrillation device. The VENTAK AV III DR adds ease-of-use features to the strong product therapy package introduced by earlier generations of the VENTAK AV series of implantable defibrillators. At 58 cc, the new device is 20 percent smaller than the VENTAK AV II DR device. The system's adaptive-rate pacing capability automatically and continuously determines pacing support required as a patient's activity changes. Further, the VENTAK AV III DR device's Atrial View(TM) feature enables treatment specificity by virtue of its ability to discriminate between ventricular rhythms that are life threatening and supraventricular (non life-threatening) arrhythmias. "The VENTAK AV III DR adds ease-of-use features -- Quick Check(TM) and Quick Notes(TM) -- to the full array of therapy and diagnostic capabilities currently available in the VENTAK AV II DR, which was market released in the United States in March," noted Jay Graf, president of Guidant's CRM group. "The VENTAK AV III DR with dual-chamber pacing therapy that includes mode switching and rate modulation provides sophisticated pacing options for patients who have a primary need for defibrillation therapy," Graf added. "The VENTAK AV III DR is another in a series of downsized defibrillators that we plan to launch in markets around the world," he added. The VENTAK AV III DR is the fourth in a series of sophisticated, full-featured, dual-chamber pacing and defibrillation devices developed and manufactured by Guidant since September 1996. The first implant occurred on April 30 at St. Michael's Hospital St. Michael's Hospital may refer to:
Sudden cardiac death (SCD) is an unexpected death due to heart problems, which occurs within one hour from the start of any cardiac-related symptoms. SCD is sometimes called cardiac arrest. . A global leader in the medical device industry, Guidant provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease. For more information on Guidant's products and services, visit the company's web site at http://www.guidant.com. CONTACT: Guidant Corporation Todd McKinney, Investor Relations, 317/971-2094 Carol Lindahl, Media Relations, 612/582-4461 Rob Allen, Media Relations, 317/971-2031 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion